Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS)

8.01 +0.01 (+0.13%) As of 11:29AM CST. Market open.

Zhejiang Cheng Yi Pharmaceutical Co., Ltd.

Shenhong Road, Building 20
7th Floor R&F Yuedu, Lane 988 Minhang District
Shanghai 201100
China
86 21 3328 3397
https://www.chengyipharma.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Chunjian Zhao	GM & Director	N/A	N/A	1978
Mr. Sun Zhan Lu	Chief Financial Officer	N/A	N/A	1978
Mr. Bing Jun Ren	VP & Director	N/A	N/A	1965
Mr. Shi Sheng Li	VP & Director	N/A	N/A	1951
Ms. Ze Hui Ke	Deputy GM, Secretary of the Board & Director	N/A	N/A	1986

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. produces and sells APIs, injections, capsules, tablets, pharmaceutical intermediates in China. The company was formerly known as Wenzhou No. 3 Pharmaceutical Factory and changed its name to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. in April 2001. Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was founded in 1966 and is headquartered in Shanghai, China.

Corporate governance

Zhejiang Cheng Yi Pharmaceutical Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.